211 related articles for article (PubMed ID: 35688478)
1. Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward.
Beierle JA; Yao EJ; Goldstein SI; Lynch WB; Scotellaro JL; Shah AA; Sena KD; Wong AL; Linnertz CL; Averin O; Moody DE; Reilly CA; Peltz G; Emili A; Ferris MT; Bryant CD
J Pharmacol Exp Ther; 2022 Aug; 382(2):167-180. PubMed ID: 35688478
[TBL] [Abstract][Full Text] [Related]
2. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
3. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
4. Liver size and lipid content differences between BALB/c and BALB/cJ mice on a high-fat diet are due, in part, to Zhx2.
Clinkenbeard EL; Turpin C; Jiang J; Peterson ML; Spear BT
Mamm Genome; 2019 Aug; 30(7-8):226-236. PubMed ID: 31321500
[TBL] [Abstract][Full Text] [Related]
5. Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.
Arguelles N; Richards J; El-Sherbeni AA; Miksys S; Tyndale RF
Biochem Pharmacol; 2022 Apr; 198():114949. PubMed ID: 35143755
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
Babalonis S; Lofwall MR; Nuzzo PA; Walsh SL
Addict Biol; 2016 Jan; 21(1):146-58. PubMed ID: 25130052
[TBL] [Abstract][Full Text] [Related]
7. Observations of urinary oxycodone and metabolite distributions in pain patients.
Elder NM; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of thermal nociceptive sensitivity and brain weight in a BALB/c reduced complexity cross.
Beierle JA; Yao EJ; Goldstein SI; Scotellaro JL; Sena KD; Linnertz CA; Willits AB; Kader L; Young EE; Peltz G; Emili A; Ferris MT; Bryant CD
Mol Pain; 2022; 18():17448069221079540. PubMed ID: 35088629
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism.
Deodhar M; Turgeon J; Michaud V
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575542
[TBL] [Abstract][Full Text] [Related]
11. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
McMillan DM; Miksys S; Tyndale RF
Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.
Lalovic B; Kharasch E; Hoffer C; Risler L; Liu-Chen LY; Shen DD
Clin Pharmacol Ther; 2006 May; 79(5):461-79. PubMed ID: 16678548
[TBL] [Abstract][Full Text] [Related]
13. Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels.
Arguelles N; Miksys S; Tyndale RF
Mol Neurobiol; 2021 Dec; 58(12):6540-6551. PubMed ID: 34581987
[TBL] [Abstract][Full Text] [Related]
14. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
[TBL] [Abstract][Full Text] [Related]
15. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
[TBL] [Abstract][Full Text] [Related]
16. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
Gaudette F; Sirhan-Daneau A; St-Onge M; Turgeon J; Michaud V
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():174-180. PubMed ID: 26655109
[TBL] [Abstract][Full Text] [Related]
17. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
18. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
Samer CF; Daali Y; Wagner M; Hopfgartner G; Eap CB; Rebsamen MC; Rossier MF; Hochstrasser D; Dayer P; Desmeules JA
Br J Pharmacol; 2010 Jun; 160(4):907-18. PubMed ID: 20590587
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in the rodent hippocampal opioid system following stress and oxycodone associated learning processes.
Chalangal J; Mazid S; Windisch K; Milner TA
Pharmacol Biochem Behav; 2022 Jan; 212():173294. PubMed ID: 34752798
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Neuroplasticity- and Stress-Related Gene Expression and Protein Levels in the Rat Hippocampus Following Oxycodone Conditioned Place Preference.
Randesi M; Contoreggi NH; Zhou Y; Rubin BR; Bellamy JR; Yu F; Gray JD; McEwen BS; Milner TA; Kreek MJ
Neuroscience; 2019 Jul; 410():274-292. PubMed ID: 31071414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]